Asian Phytoceuticals PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	84.42	62.37	125.63	82.15	98.59	100.2
Short-Term Investments	31.23	76.37	102.01	61.25	32.23	0.53
Trading Asset Securities	241.04	212.92	23.54	35.75	36.09	71.3
Cash & Short-Term Investments	356.69	351.66	251.19	179.15	166.92	172.04
Cash Growth	9.89%	40.00%	40.21%	7.33%	-2.98%	-64.14%
Accounts Receivable	1.92	3.38	0.89	0.98	0.54	1.75
Other Receivables	1.2	2.11	3.34	3.23	2.74	3.54
Receivables	3.12	5.49	4.22	4.21	3.29	5.29
Inventory	68.51	57.03	44.27	52.88	59.94	62.33
Prepaid Expenses	0.92	1.14	0.9	0.92	0.67	0.71
Other Current Assets	0.23	0.2	0.23	0.35	0.3	0.35
Total Current Assets	429.47	415.53	300.82	237.51	231.11	240.72
Property, Plant & Equipment	55.84	66.44	82.34	64.02	91.21	113.39
Long-Term Investments	106.47	136.11	303.86	365.01	346.73	331.93
Other Intangible Assets	0.66	0.61	0.79	0.24	0.36	0.5
Long-Term Deferred Tax Assets	10.59	11.18	10.75	7.11	5.05	4.16
Other Long-Term Assets	6.16	6.14	6.17	6.25	6.07	6.08
Total Assets	609.19	636.02	704.72	680.15	680.53	696.78
Accounts Payable	0.43	0.77	1.2	0.64	1.99	0.63
Accrued Expenses	16.05	16.08	16.47	14.46	14.07	16.87
Current Portion of Leases	15	13.2	13.45	12.2	18.74	18.42
Current Income Taxes Payable	3.19	5.2	10.77	12.7	9.64	9.01
Current Unearned Revenue	0.26	0.29	0.26	0.31	0.32	0.26
Other Current Liabilities	2.83	3.12	4.05	4.78	2.99	3.68
Total Current Liabilities	37.76	38.64	46.2	45.1	47.75	48.87
Long-Term Leases	2.32	10.91	22.22	1.62	15.49	31.59
Pension & Post-Retirement Benefits	21.79	22.71	19.88	18.89	17.29	17.45
Other Long-Term Liabilities	4.04	4.04	4.04	4.04	5.01	3.4
Total Liabilities	65.91	76.3	92.34	69.64	85.54	101.31
Common Stock	300	300	300	300	300	300
Additional Paid-In Capital	166.94	166.94	166.94	166.94	166.94	166.94
Retained Earnings	94.43	109.06	161.63	146.3	126.75	125.26
Comprehensive Income & Other	-21.8	-19.18	-18.88	-5.27	1.3	3.26
Total Common Equity	539.57	556.82	609.7	607.98	594.99	595.46
Minority Interest	3.71	2.89	2.69	2.53	-	-
Shareholders' Equity	543.28	559.72	612.39	610.51	594.99	595.46
Total Liabilities & Equity	609.19	636.02	704.72	680.15	680.53	696.78
Total Debt	17.32	24.11	35.67	13.82	34.23	50.01
Net Cash (Debt)	339.37	327.56	215.52	165.33	132.69	122.02
Net Cash Growth	14.28%	51.99%	30.36%	24.60%	8.74%	-74.57%
Net Cash Per Share	0.61	0.54	0.36	0.28	0.22	0.20
Filing Date Shares Outstanding	600	600	600	600	600	600
Total Common Shares Outstanding	600	600	600	600	600	600
Working Capital	391.71	376.88	254.62	192.42	183.36	191.84
Book Value Per Share	0.90	0.93	1.02	1.01	0.99	0.99
Tangible Book Value	538.9	556.22	608.91	607.74	594.64	594.96
Tangible Book Value Per Share	0.90	0.93	1.01	1.01	0.99	0.99
Land	-	8.29	8.29	8.29	8.29	8.29
Buildings	-	90.24	93.72	91.07	91.04	94.77
Machinery	-	82.06	82.71	82.49	82.74	86.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.